Wealth Enhancement Advisory Services LLC Has $35.20 Million Stock Holdings in CVS Health Corporation $CVS

Key Points

• Wealth Enhancement Advisory Services LLC raised its stake in CVS by 10.0% to 436,076 shares, worth approximately $35.20 million as of the latest 13F filing.
• CVS beat quarterly expectations with $1.09 EPS (consensus $1.00) and $105.69B revenue, and set FY2026 guidance of 5.94–6.14 EPS (sell-side estimate ~5.89).
• The company declared a quarterly dividend of $0.665 (annualized $2.66, yield ~3.7%), though the dividend payout ratio is an elevated 192.75%.

Wealth Enhancement Advisory Services LLC boosted its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 436,076 shares of the pharmacy operator's stock after purchasing an additional 39,708 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in CVS Health were worth $35,202,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. National Pension Service grew its holdings in shares of CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator's stock worth $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC lifted its holdings in CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator's stock valued at $7,873,000 after purchasing an additional 79,340 shares during the last quarter. AE Wealth Management LLC lifted its holdings in CVS Health by 6.2% during the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator's stock valued at $19,391,000 after purchasing an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator's stock valued at $16,971,000 after buying an additional 22,653 shares in the last quarter. Finally, Alpha Omega Wealth Management LLC grew its stake in CVS Health by 12.3% during the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator's stock worth $11,301,000 after buying an additional 16,418 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CVS has been the subject of a number of research analyst reports. TD Cowen reiterated a "buy" rating on shares of CVS Health in a research note on Friday, March 13th. UBS Group reaffirmed an "outperform" rating on shares of CVS Health in a report on Wednesday, December 10th. Mizuho lifted their price objective on CVS Health from $88.00 to $95.00 and gave the company an "outperform" rating in a research report on Wednesday, December 10th. Leerink Partners reissued an "outperform" rating and issued a $98.00 price objective on shares of CVS Health in a research note on Thursday, March 5th. Finally, Barclays raised their target price on CVS Health from $87.00 to $93.00 and gave the company an "overweight" rating in a research note on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $95.05.

CVS Health Stock Performance

Shares of CVS Health stock opened at $71.26 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The firm has a 50 day simple moving average of $77.30 and a 200 day simple moving average of $77.82. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The firm has a market cap of $90.66 billion, a P/E ratio of 51.64, a P/E/G ratio of 0.75 and a beta of 0.49.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.7%. The ex-dividend date is Thursday, April 23rd. CVS Health's dividend payout ratio (DPR) is presently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.